Business Wire

MEDIMAPS-GROUP

28.11.2022 15:16:37 CET | Business Wire | Press release

Share
Medimaps Group Appoints Meinhard F. Schmidt as Board Chairman; Adds Anne Le Grand and Five Additional Board Members

Medimaps Group (www.medimapsgroup.com), a Swiss/Global med-tech company specializing in image processing software for assessing bone health, today announced new appointments to its Board of Directors, effective immediately. Meinhard F. Schmidt, an international MedTech/BioTech and Digital Health executive with 25+ years of experience, has been named Board Chairman; and Anne Le Grand, an accomplished healthcare executive and consultant with 30+ years in the global healthcare technology industry, has joined as an independent board member.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221128005146/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Medimaps Group Announces Board Members: Meinhard F. Schmidt as Board Chairman, and Anne Le Grand Plus Five Other Members and One Strategic Advisor. (Photo: Business Wire)

Five additional board members and one board advisor have also been named, bolstering Medimaps investment and clinical policy expertise. Visit Medimaps website for information about the entire Medimaps Group board and leadership team.

“I’m pleased to welcome Meinhard and Anne to our Board of Directors,” said Prof. Didier Hans, Ph.D., MBA, Chief Executive Officer and Board Member of Medimaps Group. “Meinhard’s global leadership roles in diagnostics at Philips and Roche Diagnostics—and Anne’s work leading medical imaging and healthcare businesses including AI solutions—offer Medimaps significant expertise and acumen to support our immediate growth and shape our future success.”

About the Appointees:

  • Mr. Schmidt held senior leadership roles at Philips and Roche Diagnostics where he held various global senior leadership roles in Patient/Diabetes-Care, Laboratory- and PoC-Diagnostics. After that he worked as an executive at Institute Straumann as a Business Unit head and then CEO, where he was responsible for their digital group for the worldwide “Digitalization” of the Dental industry. Currently he holds board and advisory roles for public and private MedTech/Digital Health companies, focusing on growth and commercialization.
  • Ms. Le Grand served as global Vice President IBM and General Manager for Watson Health Imaging, Oncology, Genomics and Life Sciences. Prior to IBM, she held executive leadership positions at Philips Health Systems, leading the Therapeutic Care and Ultrasound divisions. Prior to that Ms. Le Grand served as SVP Healthcare of Global X-ray for GE Healthcare, where she successfully launched and refreshed portfolios across the global x-ray, mammography, and metabolic bone disease businesses. She currently holds board and consulting roles for public and private sector healthcare companies.

Additional board members include:

  • Robert Schier, Ph.D., Senior Investment Director at Zürcher Kantonalbank Asset Management (Swisscanto Private Equity). Dr. Schier sits on the Boards of Directors of many life sciences companies. He holds a degree in pharmacy from the University of Vienna and a Ph.D. in biotechnology from the University of Natural Resources and Life Sciences, Vienna.
  • Myoung-Ok Kwon, Ph.D., investment partner at Swisscom and leading digital health investments. She has 20 years of experience in healthcare investment and pharma research. At Novartis, she was responsible for research strategy and planning and portfolio review. She holds a Ph.D. in biochemistry and molecular genetics from the Friedrich Miescher Institute, Novartis, and the University of Basel.
  • Georgette Schmid, investment manager at Helvetica Capital AG. Prior to joining Helvetica Capital, Mrs. Schmid was working in the business development and investment division within the consumer goods and hotel industry. She holds a Master of Law from the University of Zurich and a Master of Business Administration (MBA) from Ecole hôtelière de Lausanne.
  • Prof. Didier Hans, Ph.D., MBA, who has been CEO of Medimaps Group since 2012. He has 25+ years of experience in dual-energy x-ray absorptiometry (DXA), bone macro- and microarchitecture, ultrasound imaging techniques, and body composition assessment. He teaches worldwide on bone and body composition imaging and osteoporosis. He holds a Ph.D. in medical physics and an Executive MBA from HEC Geneva.
  • Sarah Lumb, co-founder and managing partner of Mission Global, a freight specialist in event logistics. She played an integral part in the creation of the group, now with nearly 200 partner offices worldwide. Her business interests extend to two other companies–Ethical Pharmaceutical Consulting Service SA and Kanis SA–that have investments across a diverse range of industries, but with a particular interest in biotech, medical device, and other high-technology companies.
  • Lauren Nicola, MD (board advisor), CEO of Triad Radiology Associates in the U.S., where she is subspecialized in breast imaging and pediatric radiology. A national health policy expert, Dr. Nicola holds leadership positions at the American College of Radiology, including the chair of the Reimbursement Committee and the Medicare Access and Chip Reauthorization Act (MACRA) committee. She has been instrumental in the creation and valuation of multiple new imaging and AI codes. She holds a medical degree from Duke University School of Medicine in North Carolina, U.S.

About Medimaps Group

Medimaps Group’s medical imaging software applications based on patented multi-purpose technology with artificial intelligence capabilities provide healthcare solutions that fit seamlessly into the workflow for the benefit of the patient. TBS iNsight™ (Osteo) has been used for years in clinical practice worldwide in the field of osteoporosis. It has become the new gold standard for bone texture assessment in routine clinical practice. TBS has gained international recognition with more than 900 peer-reviewed scientific publications and is included in many guidelines and used by more than 30,000 physicians worldwide including leading healthcare institutions. Learn more at https://www.medimapsgroup.com/.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221128005146/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Canada to Join the NATO Innovation Fund to Advance the Local Defence, Security and Resilience Ecosystem21.11.2026 17:00:00 CET | Press release

Canada becomes the 25th Allied nation to back the NATO Innovation Fund, gaining access to €1.1 billion in mission-aligned capital and a co-investor network spanning the Alliance Canada announced today it is joining the NATO Innovation Fund, becoming the 25th Allied nation to commit to backing deep tech innovation to address the needs of NATO nations. The Government of Canada is committing EUR 64,590,000 (approximately CAD $100 million) to the firm, with the Business Development Bank of Canada (BDC) holding and managing Canada’s investment in the Fund. This brings total commitments to the NATO Innovation Fund to more than EUR 1.1 billion. Canadian membership will give domestic innovators access to patient capital, opportunities to accelerate the adoption of their technology by governments and businesses across the Alliance, a large network of co-investors, and lessons learned from the NIF’s work to date across 24 participating nations. “Canada has the talent, the innovation, and the amb

Persona Earns CEN/TS 18099 High Certification for Injection Attack Detection21.11.2026 15:30:00 CET | Press release

Independent evaluation of Persona's Android SDK confirms defenses against deepfakes and other injected media at the top level of the first standard Persona, the leading global identity platform, today announced that its Android SDK has earned CEN/TS 18099 High certification for injection attack detection (IAD). High certification is the top level of the European standard. The evaluation was run by CLR CERT, the certification body of Cabinet Louis Reynaud (CLR) Labs. CLR Labs is accredited under ISO/IEC 17025, the international standard for testing laboratories, and it edits CEN/TS 18099. This certificated injection attack detection is available to all Persona customers and can be activated by working with Persona's team. Injection attacks skip the camera entirely. Instead of holding a photo or mask up to a lens, fraudsters use virtual cameras, emulators and tampered devices to feed stolen, manipulated, or AI-generated media straight into the verification flow. To the system, the result

Verlinvest to Facilitate China Resources’ Full Exit From Oatly20.11.2026 22:30:00 CET | Press release

Proposed facilitation of China Resources’ exit from Oatly requires a tender offer because of Swedish law requirements Verlinvest recommends that Oatly shareholders and holders of ADSs do not tender their shares or ADSs. Verlinvest, the global, family-backed consumer-focused evergreen investment company, today announced it has entered into an agreement to acquire China Resources Enterprise, Limited’s (“China Resources”) indirect interests in Oatly Group AB (publ) (Nasdaq: OTLY) (“Oatly”), the world’s original and largest oat drink company. The transaction builds on Verlinvest’s investment in Oatly since 2016 and reinforces its conviction in the company’s long-term potential. A change in strategic direction of state-owned enterprise China Resources informed its decision to fully exit its investment in Oatly. China Resources worked constructively with Verlinvest to identify the best path for it to do so in recognition of the complexity of their joint holding structure. Under the agreement

Picsart Opens the AI Behind Its Platform to Developers & Businesses20.11.2026 20:54:00 CET | Press release

With Picsart Platform, developers can build their own video, audio, image features using 250+ models from 30+ providers, alongside Picsart's own editing models, through one API, CLI or MCP server. Key Takeaways One bundle, four ways to build: the API, the CLI, a playground to test models, and Picsart Media Studio, an MCP server that works with compatible AI assistants. One integration for image, video, audio and text generation from 250+ models across 30+ providers, with the freedom to switch models as a product evolves. Self-serve users pay per generation at competitive, published rates. Developers get access to Picsart's proprietary editing models, like Enhance and background removal, which are only available on Picsart Platform. Picsart, the AI media production and distribution platform backed by Sequoia Capital and SoftBank Vision Fund 2, today launched Picsart Platform - a multimodal creative AI hub that gives developers the technology behind the platform used by more than 100 mil

NetJets Becomes Official Private Aviation Provider of the Hahnenkamm Races in Kitzbühel20.11.2026 18:45:00 CET | Press release

The Partnership brings together two brands committed to excellence, precision and exceptional experiences NetJets, the global leader in private aviation, is delighted to announce its newest partnership with the Hahnenkamm Races in Kitzbühel, Austria, becoming the event's Official Private Aviation Provider. The Hahnenkamm Races are among the most prestigious and celebrated events in world alpine skiing. They attract athletes, business leaders, international guests and winter sports enthusiasts from around the world. Through this partnership, NetJets and the Hahnenkamm Races are aligning two brands renowned for excellence, precision and world-class experiences. The partnership is an exciting addition to NetJets' growing portfolio of premium lifestyle and sporting partnerships, offering Owners unique opportunities to access one of Europe's most iconic winter sporting events. Alongside premium hospitality and unforgettable behind-the-scenes experiences, the collaboration will help create e

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye